Vitamin D Insufficiency
November 17th, 2026FDA approves adrabetadex for infantile-onset Niemann-Pick type CThe FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.Read more
November 17th, 2026US loses measles elimination status; CDC outlines re-elimination planThe US lost measles elimination status after 26 years; CDC and partners plan to regain it via MMR vaccination and $100M in health department funding.Read more
November 17th, 2026Insurers denied 39% of pediatric allergy, asthma biologic requestsAt ACAAI 2026, 93.6% of pediatric biologic prescriptions needed prior authorization, 39.3% were denied, and approval took a mean of 33 days.Read more
November 17th, 2026Maternal deaths fall, but US still gets D+ on preterm birthUS preterm birth rate held at 10.4%, earning a fifth straight D+ from March of Dimes; maternal deaths fell, but racial disparities persist.Read more
November 16th, 2026Tirzepatide cuts BMI 18.5% in adolescents with obesityIn SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.Read more
November 16th, 2026Maternal autoantibodies linked to autism subtype, recurrence riskData presented at NSGC 2026 tie maternal autoantibody combinations to a non-genetic autism subtype with high recurrence risk in later-born siblings.Read more
November 16th, 2026Roflumilast cream 0.05% eases itch, improves QOL in infants with ADCaregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.Read more
November 16th, 2026Etavopivat for sickle cell disease submitted to FDA and EMANovo Nordisk filed etavopivat for SCD in patients aged 12+, backed by phase 3 HIBISCUS data showing a 27% drop in vaso-occlusive crises vs placebo.Read more